The board of managers at Bioventus unanimously appointed Ken Reali to succeed Tony Bihl as CEO when he retires April 20.
Mr. Reali has more than 28 years of experience in the medical device industry, including executive roles at Stryker, Smith+Nephew and Baxano Surgical.
Since 2015, he has operated as president and CEO of medical device company Clinical Innovations.
Beginning his career at Biomet, Mr. Reali progressed to marketing director and vice president at Stryker, senior vice president and general manager at Smith+Nephew and president and CEO of spinal device company Baxano Surgical.
He is on the boards of Ossio Integrative Orthopedics, AdvaMed and AdvaMed Accel and also serves as chairman of the ethics and compliance committee for AdvaMed.